Ken Griffin’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-940
Closed -$7.21K 16252
2022
Q4
$7.21K Sell
940
-3,788
-80% -$43.8K ﹤0.01% 13839
2022
Q3
$64K Buy
+4,728
New +$239K ﹤0.01% 11453
2022
Q2
Sell
-186
Closed -$52.5K 14910
2022
Q1
$54K Sell
186
-300
-62% -$72.9K ﹤0.01% 12751
2021
Q4
$102K Sell
486
-377
-44% -$104K ﹤0.01% 12711
2021
Q3
$280K Sell
863
-29
-3% -$9.03K ﹤0.01% 11204
2021
Q2
$314K Buy
892
+370
+71% +$121K ﹤0.01% 11152
2021
Q1
$200K Buy
522
+184
+54% +$79.4K ﹤0.01% 11709
2020
Q4
$137K Buy
338
+186
+122% +$80.5K ﹤0.01% 10004
2020
Q3
$64K Sell
152
-10
-6% -$4.54K ﹤0.01% 9510
2020
Q2
$83K Buy
+162
New +$79.5K ﹤0.01% 9095
2018
Q2
Sell
-22
Closed -$28K 9522
2018
Q1
$28K Buy
+22
New +$27.1K ﹤0.01% 8068
2017
Q4
Sell
-17
Closed -$15K 8682
2017
Q3
$15K Buy
+17
New +$16.1K ﹤0.01% 7412

Other funds holding CFRX

Ken Griffin's CFRX Position: Q1 2023 in Review

Ken Griffin sold out of ContraFect Corporation (CFRX) in Q1 2023, closing a stake of 940 shares — an estimated $7.21K sold.

Ken Griffin first reported a position in CFRX in Q3 2017 and held it in 12 quarters. The position peaked at $314K in Q2 2021. 19 funds tracked by Wall St. Rank hold CFRX as of Q1 2023.

  • Ken Griffin reported no remaining ContraFect Corporation position as of Q1 2023 after selling out during the quarter.
  • Ken Griffin sold 940 ContraFect Corporation shares in Q1 2023, an estimated $7.21K.
  • Ken Griffin first reported a position in ContraFect Corporation in Q3 2017 and held it in 12 quarters.
  • Ken Griffin's ContraFect Corporation position peaked at $314K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.